Universe Pharma (UPC) - Wutah bathi saben saham ing taun lumaku

UPC (Universe Pharma) - tandha merek perusahaan

The current YoY EPS growth rate demonstrates the resilience of Universe Pharmaceuticals (UPC), as demand for medications remains independent of economic cycles. Profit stability is based on the production of masks and Chinese pharmaceuticals. Revenues rely on integration into the logistics of PRC hospitals, although government regulation limits margins. Currently, this metric stands at 0.00, which captures the annual dynamics of the business's profitability.

Wutah bathi saben saham ing taun lumaku: Universe Pharmaceuticals Inc. (UPC) kanggo 04.07.2022 - 15.11.2026

Rincian metrik keuangan lan pasar Universe Pharma (UPC)

- kuotasi saiki lan rata-rata prakiraan nilai:
Ringkesan analisis perusahaan:Universe Pharma (UPC)
Produk seri Universe Pharmacy

Investors are assessing the potential of Universe Pharmaceuticals (UPC) through the dynamics of earnings per share. This ratio measures the percentage deviation of the current EPS from the previous year's value, reflecting the efficiency of the pharmacy network modernization and the R&D pipeline. The current value of 0.00, recorded as the annual EPS change ratio, confirms the business's moderate market adaptation, determining the company's degree of resilience to financial risks.